DecisionGateway
Feed Claims Market Forecasts Trajectories Domains Calendar Actors Places Labs
Beta
Blog
API Sign in
HomeClaimsThe US FDA is investigating the reported cancer risk of Novartis's gene therapy.
investigation

The US FDA is investigating the reported cancer risk of Novartis's gene therapy.

A investigation by 解药. Statements are as reported by the cited publishers — not verified by DecisionGateway.

美FDA调查
caixin_newsPublished 2026-11-10 Read source

Discussion

0/2000 Ctrl/⌘ + Enter

Related claims

Novartis's expensive gene therapy has been reported to carry a cancer risk.解药 · allegationThe FDA requires a warning about a risk of sudden blindness with popular weight-loss drugs.noticias_telemundo · statementThe Nvidia board has launched an independent internal investigation into the matter.輝達董事會 · investigationNvidia's board of directors has launched an independent investigation; the company said it does not yet see grounds to believe that trade secrets or US national security have been harmed.NVIDIA · investigationNvidia's independent board investigation remains open.post author · statementA scandal involving Nvidia underscores growing espionage risks for AI firms.theedgesg · allegation
All claims
FeedActorsForecasts